| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $335M | $333M | $375M | 0.7% | -10.8% |
| Op. Income | $105M | $92M | $125M | 14.0% | -16.6% |
| Gross Margin | 91.6% | 87.6% | 89.0% | 4.0pp | 2.6pp |
| Net Margin | 28.4% | 28.0% | 29.8% | 0.4pp | -1.4pp |
| EPS (Diluted) | $1.50 | $1.47 | $1.73 | 2.0% | -13.3% |
| Free Cash Flow | $238M | -$62M | $224M | 482.8% | 6.6% |
| Item | Amount |
|---|---|
| REVENUE | $335M |
| Cost of Revenue | $28M |
| GROSS PROFIT | $307M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $112M |
| SG&A Expenses | $112M |
| Other Expenses | $90M |
| Operating Expenses | $202M |
| Cost & Expenses | $230M |
| OPERATING INCOME | $105M |
| Interest Income | $251M |
| Interest Expense | $8M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $105M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $95M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $95M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $94M |
| D&A | $16M |
| EBIT | $105M |
| EBITDA | $121M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $335M |
| Cost of Revenue | $28M |
| GROSS PROFIT | $307M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $112M |
| SG&A Expenses | $112M |
| Other Expenses | $90M |
| Operating Expenses | $202M |
| Cost & Expenses | $230M |
| OPERATING INCOME | $105M |
| Interest Income | $251M |
| Interest Expense | $8M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $105M |
| Income Tax Expense | $10M |
| Net Income from Continuing Ops | $95M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $95M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $94M |
| D&A | $16M |
| EBIT | $105M |
| EBITDA | $121M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $95M |
| Depreciation & Amortization | $16M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $43M |
| Other Non-Cash Items | $46M |
| Change in Working Capital | $65M |
| OPERATING CASH FLOW | $268M |
| Capital Expenditure | -$30M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$4.6B |
| Sales/Maturities of Investments | $4.4B |
| Other Investing Activities | -$257M |
| NET CASH FROM INVESTING | -$489M |
| Net Debt Issuance | $19M |
| Common Stock Repurchased | -$27.0K |
| Common Dividends Paid | -$45M |
| Other Financing Activities | $823M |
| NET CASH FROM FINANCING | $797M |
| FREE CASH FLOW | $238M |
| Net Change in Cash | $576M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $7.2B |
| Short-Term Investments | $10.6B |
| Net Receivables | $483M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $18.2B |
| PP&E (Net) | $1.1B |
| Goodwill | $655M |
| Intangible Assets | $2M |
| Long-Term Investments | $19.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $235M |
| TOTAL NON-CURRENT ASSETS | $21.9B |
| TOTAL ASSETS | $40.1B |
| Account Payables | $673M |
| Short-Term Debt | $1.6B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $33.5B |
| TOTAL CURRENT LIABILITIES | $35.8B |
| Long-Term Debt | $235M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $235M |
| TOTAL LIABILITIES | $36.0B |
| Common Stock | $642.0K |
| Additional Paid-In Capital | $991M |
| Retained Earnings | $2.7B |
| Treasury Stock | -$137M |
| Accum. Other Comp. Income | $505M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $4.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $4.1B |
| TOTAL LIABILITIES & EQUITY | $40.1B |
| Total Debt | $1.8B |
| Net Debt | -$5.3B |
